Whitening &Freckle Removing Cosmetic Peptide Nonapeptide-1/Melitane/Melanostatine 98% Powder 158563-45-2

Whitening &Freckle Removing Cosmetic Peptide Nonapeptide-1/Melitane/Melanostatine 98% Powder 158563-45-2

Min.Order / FOB Price:Get Latest Price

250 Milligram	FOB Price: USD 150.0000

250 Milligram

FOB Price: USD 150.0000

Min.Order :250 Milligram
Purity: 99%
Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

Nonapeptide-1/Melitane Cosmetic Peptide 158563-45-2

Quick Details

Appearance:white powder
Application:/
PackAge:foil bag, drum, vials
ProductionCapacity:10|Kilogram|Day
Storage:/
Transportation:air

Superiority:

Large volume discount

Our advantage:
We have PEPTIDES and SARMS WAREHOUSE IN USA and Euro, you can receive order with 3 days without any customs problems.
We offer drop ship to your end clients in worldwide.

Why Choose us:
1). We have our own GMP lab .
2). Warehouses in USA and Euro to support your urgent need.
3). We can customize Peptides and Test Report HPLC and MS are available.
4). / Bank Transfer / Credit Card / Bitcoin / T/T in Advance / LC @ SIGHT / Paypal for your option.

Details:

Product description

MF:C61H87N15O9S

MW:1206.5

Density:1.38±0.1 g/cm3(Predicted)

Product introduction

Nonapeptide-1, also called Melanostatine-5, is a propriety peptide that was originally developed for its antimicrobial activities. Animal research has revealed, however, that nonapeptide-1 can inhibit the synthesis of melanin, which makes it of interest for treating certain skin conditions.Animal models suggest that nonapeptide-1 can reduce synthesis of melanin and help decrease skin pigmentation to a substantial degree.

Nonapeptide-1 is of primary research interest for its ability to reduce hyperpigmentation by inhibiting the action of tyrosinase in melanin-producing cells. The ability to regulate melanin production has potential application in a number of conditions, including photodamage of the skin.

Research also suggests that nonapeptide-1 may play a role in the central nervous system where it may act on both dopaminergic receptors and opioid receptors to modify pain signaling as well as behavior. Studies in mice support the idea that nonapeptide-1 may have central actions that affect behavior and pain.